William DeVaul

Chief Legal Officer at Cambrian BioPharma.

Raised on Cambrian BioPharma filings

$123.8M

of $129.8M offered across 1 Form D filing

Company

Biotech · New York, NY

Drugs that target the biology of aging

Drugs that target the biology of aging

Cambrian BioPharma Form D filings
Filed	Security	Sold of offered	Filing
Jul 15, 2026	Equity	$123.8M/ $129.8M	Form D

Also named on Cambrian BioPharma filings